Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late‐Life Depression, and Healthy Aging: A Preliminary Cross‐Sectional Study
Wataru Omori, Naoto Kajitani, Mami Okada‐Tsuchioka, Minoru Takebayashi · 2026
Read Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late‐Life Depression, and Healthy Aging: A Preliminary Cross‐Sectional Study by Wataru Omori, Naoto Kajitani, Mami Okada‐Tsuchioka, Minoru Takebayashi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13590209.txt.
Description
Wataru Omori and three co-authors measure a nerve-growth receptor fragment in spinal fluid in a 2026 study. The fragment, shed from the p75 neurotrophin receptor, has been tied to the toxic action of amyloid in Alzheimer's disease. Whether its levels also shift in late-life depression, which can mimic or precede dementia, was unknown.
Spinal fluid from fifty people, healthy elders, patients with late-life depression, and patients with Alzheimer's, was compared with age, sex, and body weight taken into account. Levels ran higher in the healthy and depressed groups than in the Alzheimer's group. Follow-up analyses probed links to symptoms and thinking scores, with statistical guards against false alarms from many tests. The authors call the work preliminary, a first map of a marker that may help separate depression from dementia in the clinic.
Catalog record
| CREATOR | Wataru Omori, Naoto Kajitani, Mami Okada‐Tsuchioka, Minoru Takebayashi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |